A Study in Healthy Volunteers to Assess the Effect of Fedovapagon on the QT/QTC Interval

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Healthy

Interventions

DRUG

Fedovapagon

DRUG

Moxifloxacin

DRUG

Placebo (for fedovapagon)

Trial Locations (1)

PAREXEL Early Phase Clinical Unit Berlin, Berlin

All Listed Sponsors

lead

Vantia Ltd

INDUSTRY

NCT02537288 - A Study in Healthy Volunteers to Assess the Effect of Fedovapagon on the QT/QTC Interval | Biotech Hunter | Biotech Hunter